Article
An empirical pipeline for personalized diagnosis of Lafora disease mutations
2021-03-26
Abstract excerpt
<h4>ABSTRACT</h4> Lafora disease (LD) is a fatal, insidious metabolic disorder characterized by progressive myoclonic epilepsy manifesting in the teenage years, rapid neurological decline, and death typically within ten years of onset. Mutations in either EPM2A , encoding the glycogen phosphatase laforin, or EPM2B , encoding the E3 ligase malin, cause LD. Whole exome sequencing has revealed many EPM2A variants...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 003daa57-a25f-57ad-a665-229263ff09a9
- DOI
- 10.1101/2021.03.26.437206
